Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Allopurinol Improves Diastolic Function in African Americans With Resistant Hypertension

NCT05888233 is registered in ClinicalTrials.gov with VA Office of Research and Development as lead sponsor.

NCT NCT05888233
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05888233 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Allopurinol Improves Diastolic Function in African Americans With Resistant Hypertension
Lead sponsor
VA Office of Research and Development
Phase
Phase 2
Overall status
Completed
Start date
September 30, 2024
Completion date
August 31, 2026
Enrollment
40 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

heart failure preserved ejection fraction, resistant hypertension